ISSN 2590-0048
Vol. 3, Issue 1, 2021March 23, 2021 CDT
Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Articles in Vol. 3, Issue 1, 2021
Vol. 3, Issue 1, 2021
- Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell LymphomaRita AssiNohad MasriIman Abou DalleJean El-CheikhHady GhanemAli Bazarbachi
1.
Assi R, Masri N, Abou Dalle I, El-Cheikh J, Ghanem H, Bazarbachi A. Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma. Clinical Hematology International. 2021;3(1). doi:10.46989/001c.172366